Related Experiment Video
Updated: Jul 23, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Pathophysiological and clinical point of view on Kawasaki disease and MIS-C
Lenka Vaňková1, Jiří Bufka2, Věra Křížková1
1Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University, Czech Republic.
Insights
Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) share inflammatory pathways but are distinct diseases. Differences in epidemiology, etiology, and specific pathophysiological processes differentiate them, requiring further research.
Area of Science:
- Pediatric immunology
- Infectious diseases
- Rheumatology
Background:
- Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) are pediatric inflammatory conditions with overlapping clinical features.
- Both conditions are temporally associated with infections and involve immune system alterations and systemic inflammation.
Purpose of the Study:
- To compare the pathophysiological states of Kawasaki disease and MIS-C.
- To elucidate the similarities and differences in their epidemiological, etiological, and pathophysiological aspects.
- To identify areas for future research to better understand disease development.
Main Methods:
- Comparative analysis of existing literature on Kawasaki disease and MIS-C.
- Examination of shared pathophysiological mechanisms, including interleukin-1, inflammasome activation, pyroptosis, and NETosis.
- Review of epidemiological and etiological data to differentiate the two conditions.
Main Results:
- Both Kawasaki disease and MIS-C exhibit overlapping clinical presentations and share common inflammatory pathways.
- Significant differences exist in epidemiological patterns, etiological factors, and the frequency/development of specific clinical signs.
- These distinctions confirm Kawasaki disease and MIS-C as separate entities despite shared inflammatory processes.
Conclusions:
- Kawasaki disease and MIS-C, while sharing inflammatory pathways, are distinct diseases with unique epidemiological and etiological profiles.
- Further research into understudied areas is crucial for a comprehensive understanding of their development.
- Distinguishing between these conditions is vital for appropriate diagnosis and management in pediatric populations.
Abstract:
This article compares two important pathophysiological states, Kawasaki disease, and multisystem inflammatory syndrome, in children associated with COVID-19 (MIS-C). Both occur predominantly in children, have a temporal association with an infectious agent, and are associated with immune-system alteration and systemic inflammation under certain circumstances. The two share common pathophysiology, including enhancement of interleukin-1 neutrophils, activation of the inflammasome, pyroptosis, or NETosis. Moreover, the clinical presentation of the diseases overlaps. However, they are indeed two separate diseases, proven by the differences in the epidemiological and etiological aspects and the pathophysiological processes involved in the development and frequency of some clinical signs. This article highlights potentially exciting areas that have not yet been studied in detail, which could help better understand the development of these diseases.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction